Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Remy

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
Human Gene Therapy|December 9, 2004
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I studyJ Bloch, A C Bachoud-Lévi, N Déglon, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesJ-E Gottenberg, L Guillevin, O Lambotte, et al.
La Revue De Medecine Interne|February 23, 2016
[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion]A Mathian, L Arnaud, D Adoue, et al.
La Revue De Medecine Interne|December 3, 2014
[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion]L Arnaud, A Mathian, D Adoue, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
Human Gene Therapy|December 9, 2004
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I studyJ Bloch, A C Bachoud-Lévi, N Déglon, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesJ-E Gottenberg, L Guillevin, O Lambotte, et al.
La Revue De Medecine Interne|February 23, 2016
[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion]A Mathian, L Arnaud, D Adoue, et al.
La Revue De Medecine Interne|December 3, 2014
[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion]L Arnaud, A Mathian, D Adoue, et al.
Pageof 17